Successful use of an inhalational phytochemical to treat pulmonary tuberculosis: A case report

Phytomedicine

Volumn 11, Issue 2-3, 2004, Pages 95-97

  Sherry, E ^a,c   Warnke, P H ^b  

^a NEPEAN HOSPITAL   (Australia)

^b UNIVERSITY OF KIEL   (Germany)

^c UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Case report; Eucalyptus globulus; Inhalation; Pulmonary tuberculosis

Indexed keywords

EUCALYPTUS GLOBULUS OIL; EUCALYPTUS OIL; KLONEMAX TM; PLANT EXTRACT; TUBERCULOSTATIC AGENT; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BACTERIAL STRAIN; CASE REPORT; CLINICAL FEATURE; COST EFFECTIVENESS ANALYSIS; DIRECTLY OBSERVED THERAPY; ERYTHROCYTE SEDIMENTATION RATE; EUCALYPTUS; EUCALYPTUS GLOBULUS; FEMALE; HUMAN; INHALATION; LUNG TUBERCULOSIS; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PHYTOCHEMISTRY; PRIORITY JOURNAL; SPUTUM CULTURE; THORAX RADIOGRAPHY;

BACTERIA (MICROORGANISMS); EUCALYPTUS; EUCALYPTUS GLOBULUS; MYCOBACTERIUM; MYCOBACTERIUM TUBERCULOSIS;

EID: 1542288377     PISSN: 09447113     EISSN: None     Source Type: Journal    
DOI: 10.1078/0944-7113-00378     Document Type: Article

References (16)

1. Anderson JN, Fennessy PA (2000) Can tea tree oil (Melaleuca alternifolia) prevent MRSA? Med J Aust 173: 498
2. Banes-Marshall L, Cawley P, Phillips CA (2001) In vitro activity of Melaleuca alternifolia (tea tree) oil against bacterial and Candida spp. Isolates from clinical specimens. Br J Biomed Sci 58: 139-145
3. Caelli M, Porteous J, Carson CF, Heller RF, Riley TV (2000) Tea tree oil as an alternative topical decolonization agent for methicillin-resistant Staphylococcus aureus. J Hosp Infect 46: 236-237
4. Christoph F, Kaulfers PM, Stahl-Biskup E (2001) In vitro evaluation of the antibacterial activity of beta-triketones admixed to Melaleuca oils. Planta Med 67: 768-771
5. + leakage and inhibits respiration in Escherichia coli. Lett Appl Microbiol 26: 355-358
6. D'Auria FD, Laino L, Strippoli V, et al. (2001) In vitro activity of tea tree oil against Candida albicans mycelial conversion and other pathogenic fungi. J Chemother 13: 377-383
7. Espinal MA, Laszlo A, Simonsen L, et al. (2001) Global trends in resistance to antituberculosis drugs. New Engl J Med 344: 1294-1303
8. Floyd K, Blanc L, Raviglione M, Lee J-W (2002) Resources required for global tuberculosis control. Science 295: 2040-2041
9. Griffiths PA, Babb JR, Fraise AP (1998) Mycobacterium terrae: A potential surrogate for Mycobacterium tuberculosis in a standard disinfectant test. J Hosp Infect 38: 183-192
10. Hammer KA, Carson CF, Riley TV (2000) Melaleuca alternifolia (tea tree) oil inhibits germ tube formation in Candida albicans. Med Mycol 38: 355-362
11. Pablos-Mendez A, Raviglione MC, Laszlo A, et al. (1998) Global surveillance for antituberculosis-drug resistance. New Engl J Med 338: 1641-1649
12. Program in Infectious Disease and Social Change (1999) The global impact of drug-resistant tuberculosis. Boston: Harvard Medical School
13. Sherry E, Boeck H, Warnke PH (2001a) Percutaneus treatment of chronic MRSA osteomyelitis with a novel plant-derived antiseptic. BMC Surg 1: 1
14. Sherry E, Boeck H, Warnke PH (2001b) Topical application of a new formulation of eucalyptus oil phytochemical clears methicillin-resistant Staphylococcus aureus (MRSA) infection. Am J Infect Cont 29: 346
15. Sherry E, Warnke PH. (2002) Alternative for MRSA and tuberculosis (TB): Eucalyptus and tea-tree oils as new topical antibacterials. American Academy of Orthopaedic Surgeons, Annual Meeting, February 13-17, Dallas, TX, United States
16. Small PM, Fujiwara PI (2001) Management of tuberculosis in the United States. New Engl J Med 345: 189-200